Bioventus BVS
NASDAQ BVS
$13.13 -0.32 (-2.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bioventus (BVS) Gains from Sales and Divestitures (2023 - 2025)

Updated

Bioventus (BVS) recorded Gains from Sales and Divestitures of -$81,000 in FY2025, compared with -$292,000 in FY2024.

Analysis

Bioventus (BVS) Gains from Sales and Divestitures (2023 - 2025) Analysis & Trends

  • Per Business Quant data, BVS's Gains from Sales and Divestitures was -$292,000 in FY2024 and -$3.58 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Bioventus 1.10 Bn 993.30 Mn 105.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2025 1,000.00
Jun 28, 2025 -1,000.00
Mar 29, 2025 -81,000.00
Dec 31, 2024 -292,000.00
Dec 31, 2023 -1.20 Mn
Sep 30, 2023 -1.40 Mn
Jul 1, 2023 -977,000.00
API Access

Bioventus Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BVS&period=max&api_key=YOUR_API_KEY